for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Transgene Says Data Confirms High Accuracy Of Cancer Vaccine TG4050

May 15 (Reuters) - TRANSGENE SA:

* TRANSGENE AND NEC DEMONSTRATE HIGH ACCURACY OF AI-BASED NEOANTIGEN PREDICTION FOR THE DESIGN OF INDIVIDUALIZED CANCER VACCINE TG4050

* DATA CONFIRM THAT PREDICTION ALGORITHM SUCCESSFULLY IDENTIFIES IMMUNOGENIC CANCER MUTATIONS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up